It depends on the definition of Project Intellectual Property.
Amy L. Casey, MBA, CRCP – Associate Director
LOMA LINDA UNIVERSITY HEALTH | Clinical Trial Center
11374 Mountain View Avenue, Suite C
Loma Linda, CA 92354
(909) 558-5830
Strengths: Achiever, Input, Relator, Learner, Intellection
-----Original Message-----
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org] On Behalf Of Jennifer Keller
Sent: Monday, November 09, 2015 12:14 PM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] IP Negotiations
I'm working with a faculty member to establish an Agreement with a large corporation and am struggling to get the POC to understand the issues facing us as a public institution. The POC indicates they work with other universities all the time and to alleviate the issues with IP ownership, they REQUIRE that all deliverables be placed in the public domain using the following language:
"With respect to intellectual property rights that vest immediately upon creation of the Project Intellectual Property, including but not limited to copyright and trade secrets, University hereby disclaims and disavows all such intellectual property rights. Further, University agrees that Sponsor's use of the Project Intellectual Property prior to publication, presentation, or other disclosure of the same by the University is not a misappropriation or unauthorized disclosure of the Project Intellectual Property."
Anyone seen/accepted this language?
<br>
======================================================================<br>
Instructions on how to use the RESADM-L Mailing List, including<br> subscription information and a web-searchable archive, are available<br> via our web site at http://www.healthresearch.org (click on the<br> "LISTSERV" link in the upper right corner)<br> <br> A link directly to helpful tips: http://tinyurl.com/resadm-l-help<br>
======================================================================<br>
CONFIDENTIALITY NOTICE: This e-mail communication and any attachments may contain confidential and privileged information for the use of the designated recipients named above. If you are not the intended recipient, you are hereby notified that you have received this communication in error and that any review, disclosure, dissemination, distribution or copying of it or its contents is prohibited. If you have received this communication in error, please notify me immediately by replying to this message and destroy all copies of this communication and any attachments. Thank you.
<br>
======================================================================<br>
Instructions on how to use the RESADM-L Mailing List, including<br>
subscription information and a web-searchable archive, are available<br>
via our web site at http://www.healthresearch.org (click on the<br>
"LISTSERV" link in the upper right corner)<br>
<br>
A link directly to helpful tips: http://tinyurl.com/resadm-l-help<br>
======================================================================<br>
